SORT1/LAMP2-mediated extracellular vesicle secretion and cell adhesion are linked to lenalidomide resistance in multiple myeloma
Open Access
- 18 April 2022
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 6 (8) , 2480-2495
Abstract
Multiple myeloma (MM) is a hematopoietic malignancy whose prognosis has improved with the development of new agents such as lenalidomide over the last decade. However, long-term exposure to drugs induces the acquisition of resistance by MM cells and leads to treatment failure and poor prognosis. Here, we show the molecular and cellular mechanisms of lenalidomide resistance in MM. In a comparison between lenalidomide-resistant cell lines and the parental cell lines, extracellular vesicle (EV) secretion and adherence abilities were significantly elevated in the resistant cells. Whole-transcriptome analysis revealed that the SORT1 and LAMP2 genes were key regulators of EV secretion. Silencing of these genes caused decreased EV secretion and loss of cell adhesion in the resistant cells, resulting in increased sensitivity to lenalidomide. Analysis of publicly available transcriptome data confirmed the relationship between genes related to EV secretion and cell adhesion and patient prognosis. Together, our findings reveal a novel mechanism of lenalidomide resistance in MM mediated by EV secretion and cell adhesion via SORT1 and LAMP2.Keywords
This publication has 54 references indexed in Scilit:
- BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progressionJournal of Clinical Investigation, 2013
- The genetic architecture of multiple myelomaNature Reviews Cancer, 2012
- Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasionBlood, 2011
- Cell Surface Tetraspanin CD9 Mediates Chemoresistance in Small Cell Lung CancerCancer Research, 2010
- Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living CellsJournal of Biological Chemistry, 2010
- Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targetsNature Reviews Cancer, 2007
- Wnt3/RhoA/ROCK signaling pathway is involved in adhesion-mediated drug resistance of multiple myeloma in an autocrine mechanismMolecular Cancer Therapeutics, 2007
- Global Gene Expression Profiling of Circulating Endothelial Cells in Patients with Metastatic CarcinomasCancer Research, 2006
- Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cellsMolecular Cancer Therapeutics, 2005
- Ectopic and IFN-induced expression of Fas overcomes resistance to Fas-mediated apoptosis in multiple myeloma cellsBlood, 2005